Chapter 13 Modeling Small Molecule-Compound Binding to G-Protein-Coupled Receptors

Methods in Enzymology

Volumn 460, Issue A, 2009, Pages 263-288

  Vaidehi, Nagarajan ^a   Pease, James E ^b   Horuk, Richard ^c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND;

AB INITIO CALCULATION; BIOLOGY; BIOPHYSICS; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DRUG DESIGN; DYNAMICS; LIGAND BINDING; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; REVIEW; SITE DIRECTED MUTAGENESIS; STRUCTURAL HOMOLOGY; VALIDATION STUDY; ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; GENETICS; HUMAN; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; COMPUTER SIMULATION; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 65549111760     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05213-6     Document Type: Review

References (51)

1. Akbar N., Sitkoff D., and Krystek S. A comparative study of available software for high-accuracy homology modeling: From sequence alignments to structural models. Protein Sci. 15 (2006) 808-824
2. Ashton M., Charlton M.H., Schwarz M.K., Thomas R.J., and Whittaker M. The selection and design of GPCR ligands: From concept to the clinic. Comb. Chem. High. Throughput Screen 7 (2004) 441-452
3. Ballesteros J., and Weinstein H. Integrated methods for modeling G-protein coupled receptors. Methods Neurosci. 25 (1995) 366-428
4. Becker O.M., Marantz Y., Shacham S., Inbal B., Heifetz A., Kalid O., Bar-Haim S., Warshaviak D., Fichman M., and Noiman S. G. protein-coupled receptors: In silico drug discovery in 3D. Proc. Natl. Acad. Sci. USA 101 (2004) 11304-11309
5. Becker O.M., Shacham S., Marantz Y., and Noiman S. Modeling the 3D structure of GPCRs: Advances and application to drug discovery. Curr. Opin. Drug Discov. Dev. 6 (2003) 353-361
6. Becker O.M., Dhanoa D.S., Marantz Y., Chen D., Shacham S., Cheruku S., Heifetz A., Mohanty P., Fichman M., Sharadendu A., Nudelman R., Kauffman M., and Noiman S. An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. J. Med. Chem. 49 (2006) 3116-3135
7. Bhattacharya S., Hall S.E., and Vaidehi N. Agonist-induced conformational changes in bovine rhodopsin: Insight into activation of G-protein-coupled receptors. J. Mol. Biol. 382 (2008) 539-555
8. Bhattacharya S., Hall S.E., Li H., and Vaidehi N. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: Insight into G-protein-coupled receptor activation. Biophys. J. 94 (2008) 2027-2042
9. Bissantz C., Bernard P., Hibert M., and Rognan D. Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets?. Proteins 50 (2003) 5-25
10. Canutescu A.A., Shelenkov A.A., Dunbrack Jr. R.L.,. A graph theory algorithm for protein side-chain prediction. Protein Sci. 12 (2003) 2001-2014
11. Chamberlain A.K., and Bowie J.U. Analysis of side-chain rotamers in transmembrane proteins. Biophys. J. 87 (2004) 3460-3469
12. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., and Stevens R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
13. Crozier P.S., Stevens M.J., and Woolf T.B. How a small change in retinal leads to G-protein activation: Initial events suggested by molecular dynamics calculations. Proteins 66 (2007) 559-574
14. Eswar N., Eramian D., Webb B., Shen M.Y., and Sali A. Protein structure modeling with MODELLER. Methods Mol. Biol. 426 (2008) 145-159
15. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., and Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274 (1996) 768-770
16. Freddolino P., Kalani M.Y., Vaidehi N., Floriano W., Hall S.E., Trabanino R., Kam V.W.T., Goddard III W.A.,. Predicted 3D structure for the human β2 adrenergic receptor and its binding site for agonists and antagonists. Proc. Natl. Acad. Sci. USA 101 (2004) 2736-2741
17. Ghosh A., Rapp C.S., and Friesner R.A. Generalized Born model based on a surface integral formulation. J. Phys. Chem. B 102 (1998) 10983-10990
18. 2-adrenergic receptor. Proteins 56 (2004) 67-84
19. Hall S.E., Mao A., Nicolaidou V., Finelli M., Wise E.L., Nedjai B., Kanjanapangka J., Harirchian P., Chen D., Selchau V., Ribeiro S., Schyler S., et al. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5 (2009), Mol. Pharm. (in press)
20. Hiramoto T., Nonaka Y., Inoue K., Yamamoto T., Omatsu-Kanbe M., Matsuura H., Gohda K., and Fujita N. Identification of endogenous surrogate ligands for human P2Y receptors through an in silico search. J. Pharmacol. Sci. 95 (2004) 81-93
21. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., and Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 (1989) 51-59
22. Isin B., Schulten K., Tajkhorshid E., and Bahar I. Mechanism of signal propagation upon retinal isomerization: Insights from molecular dynamics simulations of rhodpsin restrained by normal modes. Biophys. J. 95 (2008) 789-803
23. Jaakola V.P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y., Lane J.R., Ijzerman A.P., and Stevens R.C. The 2.6-angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322 (2008) 1211-1217
24. Kobilka B.K., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 28 (2007) 397-406
25. Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: Molecular modeling and mutagenesis approaches to receptor structure and function. Pharm. Ther. 103 (2004) 21-80
26. Lefkowitz R.J. Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 25 (2004) 413-422
27. Li J., Edwards P.C., Burghammer M., Villa C., and Schertler G.F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343 (2004) 1409-1438
28. McDonald I.K., and Thornton J.M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238 (1994) 777-793
29. Mailman R.B. GPCR functional selectivity has therapeutic impact. Trends Pharmacol. Sci. 28 (2007) 390-396
30. Martinez-Mayorga K., Pitman M.C., Grossfield A., Feller S.E., and Brown M.F. Retinal counterion switch mechanism in vision evaluated by molecular simulations. J. Am. Chem. Soc. 128 (2006) 16502-16503
31. Mayo S.L., Olafson B.D., Goddard III W.A.,. DREIDING-a generic force field for molecular simulations. J. Phys. Chem. 94 (1990) 8897-8909
32. Murakami M., and Kouyama T. Crystal structure of squid rhodopsin. Nature 453 (2008) 363-367
33. Niv M.Y., Skrabanek L., Filizola M., and Weinstein H. Modeling activated states of GPCRs: The rhodopsin template. J. Comput. Aided Mol. Des. 20 (2006) 437-448
34. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J. Mol. Biol. 342 (2004) 571-583
35. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le T.I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 (2000) 739-745
36. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., and Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454 (2008) 183-187
37. Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel C., Kalé L., and Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26 (2005) 1781-1802
38. Rockey W.M., and Elcock A.H. Structure selection for protein kinase docking and virtual screening: Homology models or crystal structures?. Curr. Protein Pept. Sci. 7 (2006) 437-457
39. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., Hofmann K.P., and Ernst O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455 (2008) 497-502
40. Schlyer S., and Horuk R. I want a new drug: G-protein-coupled receptors in drug development. Drug Discov. Today. 11 (2006) 481-493
41. Shacham S., Marantz Y., Bar-Haim S., Kalid O., Warshaviak D., Avisar N., Inbal B., Heifetz A., Fichman M., Topf M., Naor Z., Noiman S., and Becker O.M. PREDICT modeling and in-silico screening for G-protein coupled receptors. Proteins 57 (2004) 51-86
42. Sousa S.F., Fernandes P.A., and Ramos M.J. Protein-ligand docking: Current status and future challenges. Proteins 65 (2006) 15-26
43. Trabanino R., Hall S.E., Vaidehi N., Floriano W., and Goddard W.A. First principles prediction of the structure and function of G protein-coupled receptors: Validation for bovine rhodopsin. Biophys. J. 86 (2004) 1904-1921
44. Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., Javitch J.A., Roth B.L., Christopoulos A., Sexton P.M., Miller K.J., Spedding M., and Mailman R.B. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320 (2007) 1-13
45. Vaidehi N., Schlyer S., Trabanino R.J., Floriano W.B., Abrol R., Sharma S., Kochanny M., Koovakat S., Dunning L., Liang M., Fox J.M., de Mendonca F.L., et al. Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation. J. Biol. Chem. 281 (2006) 27613-27620
46. Vaidehi N., Floriano W.B., Trabanino R., Hall S., Freddolino P., Choi E.J., Zamanakos G., Goddard III W.A.,. Structure and function prediction for G-protein coupled receptors. Proc. Natl. Acad. Sci. USA 99 (2002) 12622-12627
47. Vogel R., Mahalingam M., Lüdeke S., Huber T., Siebert F., and Sakmar T.P. Functional role of the "ionic lock"-an interhelical hydrogen-bond network in family A heptahelical receptors. J. Mol. Biol. 380 (2008) 648-655
48. Vriend G. A molecular modeling and drug design program. J. Mol. Graph 8 (1990) 52-56
49. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., Leslie A.G., Tate C.G., and Schertler G.F. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454 (2008) 486-491
50. Wojciechowski M., and Skolnick J. Docking of small ligands to low-resolution and theoretically predicted receptor structures. J. Comput. Chem. 23 (2002) 189-197
51. Yao X., Parnot C., Deupi X., Ratnal V.R.P., Swaminath G., Farrens D., and Kobilka B.K. Coupling ligand structures to specific conformational switches in the β2 adrenoreceptor. Nat. Chem. Biol. 2 (2006) 417-422